Health
The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS – GlobeNewswire
Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS,…
- Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS, a progressive neurodegenerative dise…
Continue Reading
-
Noosa News23 hours agoWhat the numbers really say about Crisafulli’s crime crackdown
-
General23 hours agoThe US dollar’s demise has consequences for Australia
-
Noosa News20 hours agoTwo bodies found in search for missing Brisbane couple in Tasmania
-
Business23 hours agoHow soon can I become a millionaire if I invest $1,000 every month?